GSK Update Ertragssteuer Erleichterung
07 May 2020

COVID-19 – Further profits tax relief

The coronavirus crisis continues to place a considerable burden on companies. The tax authorities are therefore making it easier to offset losses incurred in 2020 against tax prepayments made for 2019.

In a bulletin from 24 April 2020, the Federal Ministry of Finance (BMF) announced another measure intended to further mitigate the consequences of the current coronavirus crisis for all taxpayers and companies operating in Germany. The tax authorities now allow offsetting losses expected for 2020 against prepayments paid for 2019 in a lump-sum procedure, making it easier than before to obtain reimbursement of such prepayments. It is another measure aimed at providing liquidity assistance.

Print


Press contact
presse@gsk.de
+49 30 203907-7763

Back

GSK Updates
  • 05 August 2022

    GSK Update: Amendments to the German Act on Evidence of the Essential Working Conditions

    Read more
  • 25 July 2022

    GSK Update: VAT-exempt management of venture capital funds

    Read more
  • 18 July 2022

    GSK Update: AIFMD review: compromises begin to emerge

    Read more
Contact person

Dr. Dirk Koch

Partner*

+49 89 288174-676

dirk.koch@gsk.de

Dr. Petra Eckl

Partner*

+49 69 710003-0

petra.eckl@gsk.de

Dominik Berka

Counsel

+49 69 710003-194

dominik.berka@gsk.de

* Partner: a partner within the meaning of the German Partnership Companies Act.
   Local Partner: not a partner within the meaning of the German Partnership Companies Act.
CO2 Neutral